Parenteral anticoagulants in heart disease: Current status and perspectives (Section II) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease

被引:31
|
作者
De Caterina, Raffaele [1 ]
Husted, Steen [2 ]
Wallentin, Lars [3 ,4 ]
Andreotti, Felicita [5 ]
Arnesen, Harald [6 ]
Bachmann, Fedor [7 ]
Baigent, Colin [8 ]
Huber, Kurt [9 ]
Jespersen, Jorgen [10 ]
Kristensen, Steen Dalby [11 ]
Lip, Gregory Y. H. [12 ]
Morais, Joao [13 ]
Rasmussen, Lars Hvilsted [14 ]
Siegbahn, Agneta [4 ]
Verheugt, Freek W. A. [15 ]
Weitz, Jeffrey I. [16 ]
机构
[1] Univ G dAnnunzio, Osped SS Annunziata, Div Cardiovasc, Chieti, Italy
[2] Aarhus Sygehus, Dept Med Cardiol, Aarhus, Denmark
[3] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[4] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[5] Catholic Univ, Dept Cardiol, Rome, Italy
[6] Oslo Univ Hosp, Dept Med, Ulleval, Norway
[7] Univ Lausanne, Dept Med, Lausanne, Switzerland
[8] Univ Oxford, Oxford, England
[9] Wilhelminenspital Stadt Wien, Dept Med 3, Vienna, Austria
[10] Univ Southern Denmark, Unit Thrombosis Res, Esbjerg, Denmark
[11] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark
[12] City Hosp, Ctr Cardiovasc Sci, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham, W Midlands, England
[13] Leiria Hosp, Leiria, Portugal
[14] Aarhus Univ Hosp, Thrombosis Ctr Aalborg, Dept Cardiol, Aalborg, Denmark
[15] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[16] Hamilton Gen Hosp, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada
关键词
Parenteral anticoagulants; coagulation; heart disease; coronary heart disease; heart failure; atrial fibrillation; MOLECULAR-WEIGHT HEPARIN; ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA INHIBITOR; VS. UNFRACTIONATED HEPARIN; EARLY INVASIVE STRATEGY; FACTOR-XA INHIBITOR; HIGH-RISK PATIENTS; ST-ELEVATION; INDUCED THROMBOCYTOPENIA;
D O I
10.1160/TH12-06-0403
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anticoagulants are a mainstay of cardiovascular therapy, and parenteral anticoagulants have widespread use in cardiology, especially in acute situations. Parenteral anticoagulants include unfractionated heparin, low-molecular-weight heparins, the synthetic pentasaccharides fondaparinux, idraparinux and idrabiotaparinux, and parenteral direct thrombin inhibitors. The several shortcomings of unfractionated heparin and of low-molecular-weight heparins have prompted the development of the other newer agents. Here we review the mechanisms of action, pharmacological properties and side effects of parenteral anticoagulants used in the management of coronary heart disease treated with or without percutaneous coronary interventions, cardioversion for atrial fibrillation, and prosthetic heart valves and valve repair. Using an evidence-based approach, we describe the results of completed clinical trials, highlight ongoing research with currently available agents, and recommend therapeutic options for specific heart diseases.
引用
收藏
页码:769 / 786
页数:18
相关论文
共 39 条
  • [1] Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Andreotti, Felicita
    Arnesen, Harald
    Bachmann, Fedor
    Baigent, Colin
    Collet, Jean-Philippe
    Halvorsen, Sigrun
    Huber, Kurt
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Lip, Gregory Y. H.
    Morais, Joao
    Rasmussen, Lars Hvilsted
    Ricci, Fabrizio
    Sibbing, Dirk
    Siegbahn, Agneta
    Storey, Robert F.
    ten Berg, Jurrien
    Verheugt, Freek W. A.
    Weitz, Jeffrey I.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2016, 115 (04) : 685 - 711
  • [2] General mechanisms of coagulation and targets of anticoagulants (Section I) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Andreotti, Felicita
    Arnesen, Harald
    Bachmann, Fedor
    Baigent, Colin
    Huber, Kurt
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Lip, Gregory Y. H.
    Morais, Joao
    Rasmussen, Lars Hvilsted
    Siegbahn, Agneta
    Verheugt, Freek W. A.
    Weitz, Jeffrey I.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 109 (04) : 569 - 579
  • [3] New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease Position Paper
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Andreotti, Felicita
    Arnesen, Harald
    Bachmann, Fedor
    Baigent, Colin
    Huber, Kurt
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Lip, Gregory Y. H.
    Morais, Joao
    Rasmussen, Lars Hvilsted
    Siegbahn, Agneta
    Verheugt, Freek W. A.
    Weitz, Jeffrey I.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (16) : 1413 - 1425
  • [4] Anticoagulants in heart disease: current status and perspectives
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Agnelli, Giancarlo
    Bachmann, Fedor
    Baigent, Colin
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Montalescot, Gilles
    Siegbahn, Agneta
    Verheugt, Freek W. A.
    Weitz, Jeffrey
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 (07) : 880 - 913
  • [5] ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease
    Rosenhek, Raphael
    Iung, Bernard
    Tornos, Pilar
    Antunes, Manuel J.
    Prendergast, Bernard D.
    Otto, Catherine M.
    Kappetein, Arie Pieter
    Stepinska, Janina
    Kaden, Jens J.
    Naber, Christoph K.
    Acarturk, Esmeray
    Gohlke-Baerwolf, Christa
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (07) : 822 - +
  • [6] Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation
    Vaccarino, Viola
    Badimon, Lina
    Bremner, J. Douglas
    Cenko, Edina
    Cubedo, Judit
    Dorobantu, Maria
    Duncker, Dirk J.
    Koller, Akos
    Manfrini, Olivia
    Milicic, Davor
    Padro, Teresa
    Pries, Axel R.
    Quyyumi, Arshed A.
    Tousoulis, Dimitris
    Trifunovic, Danijela
    Vasiljevic, Zorana
    de Wit, Cor
    Bugiardini, Raffaele
    Lancellotti, Patrizio
    Carneiro, Antonio Vaz
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (17) : 1687 - +
  • [7] Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease
    Diller, Gerhard-Paul
    Gatzoulis, Michael A.
    Broberg, Craig S.
    Aboulhosn, Jamil
    Brida, Margarita
    Schwerzmann, Markus
    Chessa, Massimo
    Kovacs, Adrienne H.
    Roos-Hesselink, Jolien
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (19) : 1858 - 1865
  • [8] Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heart
    Lecour, Sandrine
    Du Pre, Bastiaan C.
    Botker, Hans Erik
    Brundel, Bianca J. J. M.
    Daiber, Andreas
    Davidson, Sean M.
    Ferdinandy, Peter
    Girao, Henrique
    Gollmann-Tepekoeylu, Can
    Gyoengyoesi, Mariann
    Hausenloy, Derek J.
    Madonna, Rosalinda
    Marber, Michael
    Perrino, Cinzia
    Pesce, Maurizio
    Schulz, Rainer
    Sluijter, Joost P. G.
    Steffens, Sabine
    Van Linthout, Sophie
    Young, Martin E.
    Van Laake, Linda W.
    [J]. CARDIOVASCULAR RESEARCH, 2022, 118 (12) : 2566 - 2581
  • [9] Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Andreotti, Felicita
    Arnesen, Harald
    Bachmann, Fedor
    Baigent, Colin
    Huber, Kurt
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Lip, Gregory Y. H.
    Morais, Joao
    Rasmussen, Lars Hvilsted
    Siegbahn, Agneta
    Verheugt, Freek W. A.
    Weitz, Jeffrey I.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) : 1087 - 1107
  • [10] ESC Working Group on Valvular Heart Disease Position Paperuheart valve clinics: organization, structure, and experiences
    Lancellotti, Patrizio
    Rosenhek, Raphael
    Pibarot, Philippe
    Iung, Bernard
    Otto, Catherine M.
    Tornos, Pilar
    Donal, Erwan
    Prendergast, Bernard
    Magne, Julien
    La Canna, Giovanni
    Pierard, Luc A.
    Maurer, Gerald
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (21) : 1597 - 1606